BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun CY, Zhang QY, Zheng GJ, Feng B. Phytochemicals: Current strategy to sensitize cancer cells to cisplatin. Biomed Pharmacother 2019;110:518-27. [PMID: 30530287 DOI: 10.1016/j.biopha.2018.12.010] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Das S, Rahaman A, Nath R, Das Talukdar A, Nath D, Bhattacharjee S, Mandal DP, Choudhury MD, Das D, Das G, Patra JK. Effect of acetone fraction of Ottelia alismoides on the G2/M cell cycle arrest and apoptosis in the human carcinoma cell lines. Journal of Ethnopharmacology 2023;300:115729. [DOI: 10.1016/j.jep.2022.115729] [Reference Citation Analysis]
2 Zhou Z, Liu Y, Jiang X, Zheng C, Luo W, Xiang X, Qi X, Shen J. Metformin modified chitosan as a multi-functional adjuvant to enhance cisplatin-based tumor chemotherapy efficacy. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.10.167] [Reference Citation Analysis]
3 Chen S, Jiang J, Shen A, Miao Y, Cao Y, Zhang Y, Cong P, Gao P. Rewired Metabolism of Amino Acids and Its Roles in Glioma Pathology. Metabolites 2022;12:918. [DOI: 10.3390/metabo12100918] [Reference Citation Analysis]
4 Barbolina MV. Targeting Microtubule-Associated Protein Tau in Chemotherapy-Resistant Models of High-Grade Serous Ovarian Carcinoma. Cancers (Basel) 2022;14:4535. [PMID: 36139693 DOI: 10.3390/cancers14184535] [Reference Citation Analysis]
5 Ranasinghe R, Mathai ML, Zulli A. Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon 2022;8:e10608. [PMID: 36158077 DOI: 10.1016/j.heliyon.2022.e10608] [Reference Citation Analysis]
6 Loren P, Lugones Y, Saavedra N, Saavedra K, Páez I, Rodriguez N, Moriel P, Salazar LA. MicroRNAs Involved in Intrinsic Apoptotic Pathway during Cisplatin-Induced Nephrotoxicity: Potential Use of Natural Products against DDP-Induced Apoptosis. Biomolecules 2022;12:1206. [DOI: 10.3390/biom12091206] [Reference Citation Analysis]
7 Domingo IK, Latif A, Bhavsar AP. Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity. IJMS 2022;23:7227. [DOI: 10.3390/ijms23137227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Alem D, Canclini L, Castro-sowinski S, Martínez-lópez W. Chemosensitizer Effect of Violacein on Cisplatin-treated Bladder Cancer Cells. Clinical Complementary Medicine and Pharmacology 2022;2:100036. [DOI: 10.1016/j.ccmp.2022.100036] [Reference Citation Analysis]
9 Shi L, Shu Y, Hu X, Akram W, Wang J, Dong S, Luo B, Zhang J, Hu S, Li X, Hu X. An Optimized Two-Herb Chinese Food as Medicine Formula Reduces Cisplatin-Induced Nephrotoxicity in the Treatment of Lung Cancer in Mice. Front Pharmacol 2022;13:827901. [PMID: 35355712 DOI: 10.3389/fphar.2022.827901] [Reference Citation Analysis]
10 Liu Z, Xu Y, Bai X, Guo L, Li X, Gao J, Teng Y, Yu P. Prediction of the mechanisms of action of Zhibai Dihaung Granule in cisplatin-induced acute kidney injury: A network pharmacology study and experimental validation. J Ethnopharmacol 2022;292:115241. [PMID: 35351575 DOI: 10.1016/j.jep.2022.115241] [Reference Citation Analysis]
11 Demir M, Altındağ F. Sinapic acid ameliorates cisplatin‐induced disruptions in testicular steroidogenesis and spermatogenesis by modulating androgen receptor, proliferating cell nuclear antigen and apoptosis in male rats. Andrologia. [DOI: 10.1111/and.14369] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Abdel-rahman LH, Shaker S. Adam M, Al-zaqri N, Shehata MR, El-sayed Ahmed H, Mohamed SK. Synthesis, characterization, biological and docking studies of ZrO(II), VO(II) and Zn(II) complexes of a halogenated tetra-dentate Schiff base. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.103737] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Jahani S, Ghiasi M. Platinum complexation with glutamate amino acid: Computational study. MGC 2021;20:547-56. [DOI: 10.3233/mgc-210071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kubczak M, Szustka A, Rogalińska M. Molecular Targets of Natural Compounds with Anti-Cancer Properties. Int J Mol Sci 2021;22:13659. [PMID: 34948455 DOI: 10.3390/ijms222413659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
15 Karimi-Maleh H, Khataee A, Karimi F, Baghayeri M, Fu L, Rouhi J, Karaman C, Karaman O, Boukherroub R. A green and sensitive guanine-based DNA biosensor for idarubicin anticancer monitoring in biological samples: A simple and fast strategy for control of health quality in chemotherapy procedure confirmed by docking investigation. Chemosphere 2021;:132928. [PMID: 34800513 DOI: 10.1016/j.chemosphere.2021.132928] [Cited by in Crossref: 127] [Cited by in F6Publishing: 141] [Article Influence: 127.0] [Reference Citation Analysis]
16 Wang W, Chen L, Zhu W, Huang X, Lin L, Quan Z, Sun K, Xu Q. miR-4486 reverses cisplatin-resistance of colon cancer cells via targeting ATG7 to inhibiting autophagy. Exp Ther Med 2021;22:1465. [PMID: 34737805 DOI: 10.3892/etm.2021.10900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Fetoni AR, Paciello F, Troiani D. Cisplatin chemotherapy and cochlear damage: otoprotective and chemosensitization properties of polyphenols. Antioxid Redox Signal 2021. [PMID: 34731023 DOI: 10.1089/ars.2021.0183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Feng N, Guo Z, Wu X, Tian Y, Li Y, Geng Y, Yu Y. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis. Respir Res 2021;22:248. [PMID: 34537072 DOI: 10.1186/s12931-021-01840-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
19 Sahin TK, Bilir B, Kucuk O. Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy. Crit Rev Food Sci Nutr 2021;:1-15. [PMID: 34529530 DOI: 10.1080/10408398.2021.1976721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Fontana F, Marzagalli M, Raimondi M, Zuco V, Zaffaroni N, Limonta P. δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis. Cell Prolif 2021;54:e13111. [PMID: 34520051 DOI: 10.1111/cpr.13111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
21 Li R, Chen J, Gao X, Jiang G. Transcription factor KLF2 enhances the sensitivity of breast cancer cells to cisplatin by suppressing kinase WEE1. Cancer Biol Ther 2021;22:465-77. [PMID: 34486497 DOI: 10.1080/15384047.2021.1949228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Shahedi A, Bolorizadeh MA, Karimi-maleh H. A europium (III) complex tested for deoxyribonucleic acid-binding, bovine serum albumin binding, and antibacterial activity. Journal of Molecular Liquids 2021;335:116323. [DOI: 10.1016/j.molliq.2021.116323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Catalán M, Rodríguez C, Olmedo I, Carrasco-Rojas J, Rojas D, Molina-Berríos A, Díaz-Dosque M, Jara JA. Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin. Adv Exp Med Biol 2021;1326:95-109. [PMID: 33368015 DOI: 10.1007/5584_2020_603] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Turtoi M, Anghelache M, Bucatariu SM, Deleanu M, Voicu G, Safciuc F, Manduteanu I, Fundueanu G, Simionescu M, Calin M. A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells. Int J Biol Macromol 2021;185:604-19. [PMID: 34216662 DOI: 10.1016/j.ijbiomac.2021.06.174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
25 Zhi D, Yang T, Zhang T, Yang M, Zhang S, Donnelly RF. Microneedles for gene and drug delivery in skin cancer therapy. Journal of Controlled Release 2021;335:158-77. [DOI: 10.1016/j.jconrel.2021.05.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
26 Sha J, Bai Y, Ngo HX, Okui T, Kanno T. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition. Biomolecules 2021;11:893. [PMID: 34208465 DOI: 10.3390/biom11060893] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
27 More MP, Pardeshi SR, Pardeshi CV, Sonawane GA, Shinde MN, Deshmukh PK, Naik JB, Kulkarni AD. Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer. Medicine in Drug Discovery 2021;10:100082. [DOI: 10.1016/j.medidd.2021.100082] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
28 Pursuwani BH, Bhatt BS, Raval DB, Thakkar VR, Sharma J, Pathak C, Patel MN. Synthesis, characterization, and biological applications of pyrazole moiety bearing osmium(IV) complexes. Nucleosides Nucleotides Nucleic Acids 2021;40:593-618. [PMID: 34047249 DOI: 10.1080/15257770.2021.1921795] [Reference Citation Analysis]
29 Gu S, Wu Q, Li Y, Jia W, Zhang D, Jiao L, Zhang Y. Investigation of differentially expressed gene profile for cisplatin-treated lung cancer patients. Anticancer Drugs 2021;32:875-81. [PMID: 33967201 DOI: 10.1097/CAD.0000000000001075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Issinger OG, Guerra B. Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling. Biomed Pharmacother 2021;139:111650. [PMID: 33945911 DOI: 10.1016/j.biopha.2021.111650] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
31 Li X, Zhao J, Yan T, Mu J, Lin Y, Chen J, Deng H, Meng X. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells. J Food Sci 2021;86:2700-12. [PMID: 33908630 DOI: 10.1111/1750-3841.15740] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
32 Devarajan N, Manjunathan R, Ganesan SK. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients. Crit Rev Oncol Hematol 2021;162:103327. [PMID: 33862250 DOI: 10.1016/j.critrevonc.2021.103327] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
33 Chiang CS, Shih IJ, Shueng PW, Kao M, Zhang LW, Chen SF, Chen MH, Liu TY. Tumor cell-targeting radiotherapy in the treatment of glioblastoma multiforme using linear accelerators. Acta Biomater 2021;125:300-11. [PMID: 33609743 DOI: 10.1016/j.actbio.2021.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
34 Zhang K, Shao CX, Zhu JD, Lv XL, Tu CY, Jiang C, Shang MJ. Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma. Biosci Rep. 2020;40:BSR20194026. [PMID: 32463473 DOI: 10.1042/bsr20194026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
35 Li J, Xu X, Zhang D, Lv H, Lei X. LncRNA LHFPL3-AS1 Promotes Oral Squamous Cell Carcinoma Growth and Cisplatin Resistance Through Targeting miR-362-5p/CHSY1 Pathway. Onco Targets Ther 2021;14:2293-300. [PMID: 33833527 DOI: 10.2147/OTT.S298679] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
36 Huang J, Liu C, Duan S, Lin J, Luo Y, Tao S, Xing S, Zhang X, Du H, Wang H, Huang C, Wei G. Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway. Life Sci 2021;274:119354. [PMID: 33737087 DOI: 10.1016/j.lfs.2021.119354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Yin Z, Chen E, Cai X, Gong E, Li Y, Xu C, Ye Z, Cao Z, Pan J. Baicalin attenuates XRCC1-mediated DNA repair to enhance the sensitivity of lung cancer cells to cisplatin. J Recept Signal Transduct Res 2021;:1-10. [PMID: 33719846 DOI: 10.1080/10799893.2021.1892132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Khine HEE, Ecoy GAU, Roytrakul S, Phaonakrop N, Pornputtapong N, Prompetchara E, Chanvorachote P, Chaotham C. Chemosensitizing activity of peptide from Lentinus squarrosulus (Mont.) on cisplatin-induced apoptosis in human lung cancer cells. Sci Rep 2021;11:4060. [PMID: 33603033 DOI: 10.1038/s41598-021-83606-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
39 Luo L, Sun W, Zhu W, Li S, Zhang W, Xu X, Fang D, Grahn THM, Jiang L, Zheng Y. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism. Cell Death Dis 2021;12:169. [PMID: 33568627 DOI: 10.1038/s41419-021-03456-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 20.0] [Reference Citation Analysis]
40 Zhang J, Zhao T, Wang C, Meng Q, Huo X, Wang C, Sun P, Sun H, Ma X, Wu J, Liu K. Catalpol-Induced AMPK Activation Alleviates Cisplatin-Induced Nephrotoxicity through the Mitochondrial-Dependent Pathway without Compromising Its Anticancer Properties. Oxid Med Cell Longev 2021;2021:7467156. [PMID: 33510841 DOI: 10.1155/2021/7467156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Chen Z, Zeng Z, Zhu S, Zeng Y, Lin Q, Luo L, Hong X. Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts. Sci Rep 2021;11:1040. [PMID: 33441838 DOI: 10.1038/s41598-020-80198-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Wróblewska-Łuczka P, Grabarska A, Florek-Łuszczki M, Plewa Z, Łuszczki JJ. Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells. Int J Mol Sci 2021;22:E537. [PMID: 33430369 DOI: 10.3390/ijms22020537] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
43 Li Q, Liu X, Yan W, Chen Y. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma. Aging (Albany NY) 2020;13:2593-603. [PMID: 33323546 DOI: 10.18632/aging.202297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Xue D, Zhou X, Qiu J. Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma. J Pharm Pharmacol 2021;73:98-109. [PMID: 33791802 DOI: 10.1093/jpp/rgaa027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Mosca L, Vitiello F, Coppola A, Borzacchiello L, Ilisso CP, Pagano M, Caraglia M, Cacciapuoti G, Porcelli M. Therapeutic Potential of the Natural Compound S-Adenosylmethionine as a Chemoprotective Synergistic Agent in Breast, and Head and Neck Cancer Treatment: Current Status of Research. Int J Mol Sci 2020;21:E8547. [PMID: 33202711 DOI: 10.3390/ijms21228547] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
46 Sun HJ, Leng B, Wu ZY, Bian JS. Polysulfide and Hydrogen Sulfide Ameliorate Cisplatin-Induced Nephrotoxicity and Renal Inflammation through Persulfidating STAT3 and IKKβ. Int J Mol Sci 2020;21:E7805. [PMID: 33096924 DOI: 10.3390/ijms21207805] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
47 Lou JS, Zhao LP, Huang ZH, Chen XY, Xu JT, Tai WC, Tsim KWK, Chen YT, Xie T. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer. Phytomedicine 2021;80:153370. [PMID: 33113504 DOI: 10.1016/j.phymed.2020.153370] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 30.0] [Reference Citation Analysis]
48 Lin Z, Lu S, Xie X, Yi X, Huang H. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomed Pharmacother 2020;131:110768. [PMID: 33152930 DOI: 10.1016/j.biopha.2020.110768] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
49 Mehanna MM, Mneimneh AT, Abed El Jalil K. Levofloxacin-loaded naturally occurring monoterpene-based nanoemulgel: a feasible efficient system to circumvent MRSA ocular infections. Drug Dev Ind Pharm 2020;46:1787-99. [PMID: 32896171 DOI: 10.1080/03639045.2020.1821048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
50 Hasanpoor Z, Mostafaie A, Nikokar I, Hassan ZM. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells. International Journal of Biological Macromolecules 2020;159:137-53. [DOI: 10.1016/j.ijbiomac.2020.04.130] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
51 Chou ST, Ho BY, Tai YT, Huang CJ, Chao WW. Bidirect effects from cisplatin combine with rosmarinic acid (RA) or hot water extracts of Glechoma hederacea (HWG) on renal cancer cells. Chin Med 2020;15:77. [PMID: 32760434 DOI: 10.1186/s13020-020-00358-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
52 Allegra M, D'Anneo A, Frazzitta A, Restivo I, Livrea MA, Attanzio A, Tesoriere L. The Phytochemical Indicaxanthin Synergistically Enhances Cisplatin-Induced Apoptosis in HeLa Cells via Oxidative Stress-Dependent p53/p21waf1 Axis. Biomolecules 2020;10:E994. [PMID: 32630700 DOI: 10.3390/biom10070994] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
53 Bostan M, Radu N, Babeanu N, Zaharie MG, Tanasescu CAH. Biological properties of a biomaterial obtained from Syzygium aromaticum. Molecular Crystals and Liquid Crystals 2019;695:45-52. [DOI: 10.1080/15421406.2020.1723905] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Xue D, Pan ST, Zhou X, Ye F, Zhou Q, Shi F, He F, Yu H, Qiu J. Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma. Oxid Med Cell Longev 2020;2020:5649174. [PMID: 32308804 DOI: 10.1155/2020/5649174] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
55 Wróblewska A, Matczuk M. First application of CE‐ICP‐MS for monitoring the formation of cisplatin targeting delivery systems with gold nanocarriers. ELECTROPHORESIS 2020;41:394-8. [DOI: 10.1002/elps.201900438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
56 Liedtke KR, Freund E, Hermes M, Oswald S, Heidecke CD, Partecke LI, Bekeschus S. Gas Plasma-Conditioned Ringer's Lactate Enhances the Cytotoxic Activity of Cisplatin and Gemcitabine in Pancreatic Cancer In Vitro and In Ovo. Cancers (Basel) 2020;12:E123. [PMID: 31906595 DOI: 10.3390/cancers12010123] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
57 Sun C, Nie J, Huang J, Zheng G, Feng B. Targeting STAT3 inhibition to reverse cisplatin resistance. Biomedicine & Pharmacotherapy 2019;117:109135. [DOI: 10.1016/j.biopha.2019.109135] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
58 Luo Y, Fu Y, Huang R, Gao M, Liu F, Gui R, Nie X. CircRNA_101505 sensitizes hepatocellular carcinoma cells to cisplatin by sponging miR-103 and promotes oxidored-nitro domain-containing protein 1 expression. Cell Death Discov 2019;5:121. [PMID: 31372241 DOI: 10.1038/s41420-019-0202-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 13.0] [Reference Citation Analysis]
59 Roy M, Datta A. Improvement of Cancer Therapy Using Phytochemicals. Cancer Genetics and Therapeutics 2019. [DOI: 10.1007/978-981-13-9471-3_6] [Reference Citation Analysis]